Programme THURSDAY, 12 APRIL 2018
DR AND RVO
08.30 Safety of intravitreal treatments
09:15 Differences in efficacy among the intravitreal treatments for DME
09.45 Regimens of treatment and criteria for dealing with poor responders, optimize the results, and lower the burden of treatment
10:30 COFFEE BREAK
11:00 Real life data of DME intravitreal treatments and patients management
11.30 PDR treatment with anti-VEGF: beyond protocol results what is his clinical application?
12.00 Intravitreal steroids and anti-VEGF treatment of ME in RVO
12:45 LUNCH
13.45 Cases study of management and monitoring of DME
14.30 Cases study of management and monitoring of ME in RVO
15.15 Cases study of management and monitoring of PDR
16.00 – 16.45 Cases study of management and monitoring of other vascular retinopathies (Von-Hipple, Leber-Coats etc.)